Medicine

Arcutis’ Zoryve Shows Progress for Individuals with Atopic, Seborrheic Dermatitis

admin January 17, 2024

Company displayed findings at the 2024 Winter Clinical Dermatology Conference in Hawaii demonstrating significant improvements in atopic dermatitis and seborrheic dermatitis.

LEAVE A RESPONSE Cancel reply

admin

View all posts

Medicine

Cityblock Health Announces Further Partnerships with Centene Corporation to Bring Value-Based Healthcare to Florida

admin May 25, 2024

Medicine

Havas Launches GLP-1 Focused Content Platform

admin January 12, 2025

Medicine

AstraZeneca, Nona Biosciences Strike Global License and Option Deal to Develop Monoclonal Antibodies for Tumor Targeted Therapies

admin May 24, 2024

Medicine

FDA Fast Tracks GSK's Bepirovirsen for Chronic Hepatitis B Virus

admin February 13, 2024

Kwarlay.com

Kwarlay.com

Arcutis’ Zoryve Shows Progress for Individuals with Atopic, Seborrheic Dermatitis

LEAVE A RESPONSE Cancel reply

admin

Cityblock Health Announces Further Partnerships with Centene Corporation to Bring Value-Based Healthcare to Florida

Havas Launches GLP-1 Focused Content Platform

AstraZeneca, Nona Biosciences Strike Global License and Option Deal to Develop Monoclonal Antibodies for Tumor Targeted Therapies

FDA Fast Tracks GSK's Bepirovirsen for Chronic Hepatitis B Virus

Recent Posts

Archives

Categories

Arcutis’ Zoryve Shows Progress for Individuals with Atopic, Seborrheic Dermatitis

LEAVE A RESPONSE Cancel reply

admin

You Might Also Like

Cityblock Health Announces Further Partnerships with Centene Corporation to Bring Value-Based Healthcare to Florida

Havas Launches GLP-1 Focused Content Platform

AstraZeneca, Nona Biosciences Strike Global License and Option Deal to Develop Monoclonal Antibodies for Tumor Targeted Therapies

FDA Fast Tracks GSK's Bepirovirsen for Chronic Hepatitis B Virus

Recent Posts

Archives

Categories